Ovoca Bio Balance Sheet Health
Financial Health criteria checks 5/6
Ovoca Bio has a total shareholder equity of €2.2M and total debt of €0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are €3.1M and €862.0K respectively. Ovoca Bio's EBIT is €266.0K making its interest coverage ratio -29.6. It has cash and short-term investments of €2.9M.
Key information
0%
Debt to equity ratio
€0
Debt
| Interest coverage ratio | -29.6x |
| Cash | €2.93m |
| Equity | €2.24m |
| Total liabilities | €862.00k |
| Total assets | €3.10m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: OVXA's short term assets (€3.1M) exceed its short term liabilities (€863.0K).
Long Term Liabilities: OVXA's short term assets (€3.1M) do not cover its long term liabilities (€-1,000.0).
Debt to Equity History and Analysis
Debt Level: OVXA is debt free.
Reducing Debt: OVXA had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable OVXA has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: OVXA is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 6% per year.